Get the latest tech news
White House Asks FDA To Review Pharma Advertising On TV
President Trump on Tuesday issued a memorandum directing the FDA and HHS to crack down on misleading direct-to-consumer prescription drug ads, requiring clearer disclosure of risks and ensuring that promotions don't overstate benefits or push costly drugs over generics. Longtime Slashdot reader sini...
President Trump on Tuesday issued a memorandum directing the FDA and HHS to crack down on misleading direct-to-consumer prescription drug ads, requiring clearer disclosure of risks and ensuring that promotions don't overstate benefits or push costly drugs over generics. Longtime Slashdot reader sinij shares an excerpt from the memorandum: The Secretary of Health and Human Services shall therefore take appropriate action to ensure transparency and accuracy in direct-to-consumer prescription drug advertising, including by increasing the amount of information regarding any risks associated with the use of any such prescription drug required to be provided in prescription drug advertisements, to the extent permitted by applicable law. "Advertising dollars is a major avenue for pharmaceutical companies to influence news and attempt to shape public opinion," comments sinij.
Or read this on Slashdot
